drugset / Trial / NCT05189028

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

NCT05189028 ↗

Phase 3 Unknown 290 enrolled Chuangzhen Chen
RandomizedParallel-groupSingle-blindTreatment

Summary

This phase III randomized prospective clinical study was conducted to compare the short-term and long-term outcomes of gemcitabine and cisplatin neoadjuvant chemotherapy versus definite cisplatin weekly concurrent chemoradiotherapy in patients with locally advanced bulk cervical cancer.

Timeline

Start
2021-07-01
Primary completion
2025-06
Completion
2025-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Gemcitabine Small molecule — —

Indications